All Episodes
Votes & Verdicts — 157 episodes
Policy & Litigation 2H Catalysts for Investors
Trump’s Cuba Plan and Business Implications
Bayer Roundup Suit’s SCOTUS Chances, Risks
Marijuana Rescheduling in Washington
Bayer Appeal of Roundup Suits at Supreme Court
Social Media Addicts, Seed Antitrust, AI Tax
Joyce Adetutu on Tariff Risks, Refunds
Can Trump Fix the Housing Affordability Pinch?
Why Mortgage Rates Are Stuck Above 6%
Proposed Ban on Institutional Home Ownership
Iran, Musk v. OpenAI, Live Nation, Visa, Pot
Treyz on Trump, Iran, Fed, Midterms, Tariffs
Trump’s Influence on Energy, Gasoline Prices
Ret. Col. Wayne Sanders on the Iran War
Betting on Prediction Markets — Path Ahead
Cato’s Skorup on Risks to Broadcast Licenses
Bank Rules, Anthropic, Sable, DOJ v. Powell
Sayyed on the State of Antitrust Enforcement
Bayer, Abbott, J&J Billion-Dollar Tort Risk
SCOTUS Tariff-Ruling Aftermath With Ted Murphy
Joyce Adetutu on SCOTUS IEEPA Tariff Ruling
Live Nation Antitrust, Kalshi, Nexstar-Tegna
Coinbase CLO Grewal on Crypto, Event Contracts
Ted Murphy on SCOTUS IEEPA Tariff Ruling
Orsted, Equinor, Peers in Offshore Headwinds
Credit Card Caps, FCC Fines, Powell Probe
NJ AG Platkin on AI, CFPB, Kalshi, Trump
Legal, Policy Catalysts for Investors 2026
Netflix/Paramount Antitrust, AI EO, Farm Aid
Warner Bros. Bids, Zillow, Bayer in SCOTUS
Meta Win, Trump’s AI Order, Epstein/JPMorgan
ACA Future, CFPB Funds, Visa/Mastercard Pact
Tariffs in SCOTUS; Pfizer v. Novo, Metsera
Trump in Asia, SNAP, H-1Bs, Apple Antitrust
IPOs, Trump v. NYT, FTC v. PBMs, BNP Paribas
Shutdown, Crypto, Fannie-Freddie, Musk’s Pay
Shutdown, H-1B Visas, Google, Abbott/Reckitt
Zillow Antitrust, TikTok, Tariffs, Shutdown
H-1B Fees, Anthropic, Shutdown Odds, Kenvue
Shutdown, Kimmel, Trump/NYT, FTC/LiveNation
Tariff Regulatory Risk? Ask a Trade Lawyer
Google Ruling, Tariffs/SCOTUS, Cook v. Trump
Cook v. Trump, Nexstar/Tegna, Govt. Shutdown
BI’s Larry Tabb on SEC’s Project Crypto
Trump on Fannie-Freddie, 401(k)s and Powell
Trump M&A, PBMs, Tariffs, FCC Broadcast Regs
Tariffs Legality, DC Shutdown, Dick’s M&A
Robinhood’s Gallagher on Tokenization, Crypto
Legality of Trump’s Tariffs With Professor Yoo
Bank Deregulation, Tariff Rulings Among 2H Catalysts
Tax Bill’s Impact on Solar, Health Care, AI
AI Copyright Rulings, Trump Antitrust, PBMs
‘L Day’ Tariff Legality, With Stanford’s Sykes
GENIUS Act, Texas v. BlackRock, DOJ v. Visa
Wells Fargo, Fed, DOJ v. Google, TikTok Ban
Tariff Rulings, Fannie-Freddie, FTC v. Pepsi
Tax Bill, Spectrum Auctions, Fannie-Freddie
Berman on Antitrust: View from Plaintiff Bar
IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts
Tariff Suits, Broadcast Caps, Crypto Bills
Trump’s First 100 Days, Trade, Taxes and More
Tariff Suits, Tech Antitrust and Tax Bill
Meta Trial, Google Hearing, House Tax Vote
Trump’s Liberation Day: A Trade Lawyer’s Take: Votes & Verdicts
Are Trump’s Tariffs Legal? TikTok Ban Update
Trump SEC, Tariffs, FTC Firings, FCC Subsidy
Broadcasters Take Shot at FCC Media Limits
OpenAI, Meta Fair Use Bids Risky in Copyright Drama
Abbott, Apple, Citi, Nexstar, Musk, OpenAI
Ex-FBI Chief of Staff on Risks to Business
Arizona AG Mayes on Antitrust, PFAS and More
PFAS Could Make a Comeback Under Trump EPA
Washington Predictions — Tariffs, Tax, Trump
O’Rielly on the FCC’s Regulation Under Trump
TikTok Countdown After Supreme Court Showdown
Trump, TikTok, US Steel Among 2025 Catalysts
Abbott-Reckitt Multibillion-Dollar NEC Suits
Arm, Bayer, Google, Kroger, Novo, TikTok
Is the TMT Playbook About to Be Rewritten Under Trump?
Antitrust Under Trump – Post-Election View
Trump’s Win and Its Industry Impacts
Harris, Trump and Election Effects on Energy
Harris, Trump Election Impact on Antitrust
Harris, Trump Election Impact on Consumer
Harris, Trump Election Impact on Industrials
Harris, Trump Election Effect on Health-Care
Nixon Peabody Trust Company's Kern on Elections, Global Markets
Tax Implications of the 2024 US Election
BI Analysts Discuss US Election Impact on TMT
BI Strategists on the 2024 US Elections and Their Market Impact
Harris, Trump Election Effects on Financials
TikTok-Ban Risk Soars After Key Court Hearing
Bayer, Abbott Billion-Dollar Mass-Tort Risk
Anthony Scaramucci on Trump v. Harris
Coinbase, Google, TikTok and Other Catalysts
Medicare’s First Negotiated Price List Is Here
Forever Chemicals, the Forever Litigation?
Alphabet, Amazon, Apple and Meta Antitrust Showdown Status
Artificial Intelligence’s Antitrust Concerns
US Elections, GSK, Kroger and More Catalysts: Votes and Verdicts
Robinhood's Gallagher, BI's Tabb on Gensler's SEC
Joe Grogan’s Outlook for Health-Care Policy
Chevron Doctrine’s Demise and Industry Risk
US Elections, Google, Basel III Are 2H Keys
Lyft, Uber and the California Prop. 22 Brief
Kraninger on Bank Regulations, CFPB, Crypto
Net Neutrality Gets Another Day in Court
Calabria on Fannie, Freddie Conservatorships
Catalysts for Apple, Alphabet, GSK, and Visa
Todd Phillips on Basel III, Chevron, Crypto
Durbin on Credit Cards, Airline Programs
Medicare’s Hospital-at-Home and Other Reforms
Is TikTok on the Countdown to a Shutdown?
Google, LiveNation, Uber and Other Catalysts
Kelleher on FinReg, ‘Kangaroo’ Courts
Pharma and Biotech Drug Pricing Policy Outlook
Antitrust Enforcers’ New Merger Guidelines
Eugene Scalia on Beating Regulators in Court
Market and Reimbursement Outlook for Cell and Gene Therapies
3M, Synopsys, Capital One & Other Catalysts
Can Legal State Pot Put US Law Up in Smoke?
Biden’s Lab-Developed Test Proposal
Biden’s Drug-Pricing Expansion Plan, Part 2
Apple, Bayer, Moderna and Other Catalysts
Apple’s Antitrust App-Store Battle With Epic
Washington’s Crowded Outlook for 2024
Biden’s Drug Pricing March-in Proposal
Meta’s Biggest Legal, Regulatory Questions
Antitrust Changes Could Hinder M&A
Apple, Disney, Novo Nordisk, Other Catalysts
J&J, 3M's Chap 11 Play in Talc, Earplug Mass Torts
Berkshire, Google, Pega & Other Catalysts
Consumer Finance Impact of a CFPB Run Amok
Will IRA Drug Pricing Raise Employer Costs?
JJCI, Bayer, GSK, Mass Tort Litigation Risks
Bausch, GBTC, Merck, Meta & Other Catalysts
AI’s Biggest Legal and Regulatory Questions
FTC BioPharma M&A Approach Clashes With Sector
Likelihood Medicare Will Cover Obesity Drugs
3M, Drug Pricing, Google and Other Catalysts
Can Anyone Defeat Trump? Insights on the Forthcoming GOP Debates
3M, Google, Bank Rules, Other 2H Catalysts
Craig Burton on Inflation Reduction Act
Why PFAS Legal Risks Persist for 3M, Peers
Why a TikTok Ban Faces a Major Legal Hurdle
Catalysts to Watch – AI Laws, PFAS Trial
Adamantine’s Bays on Sustainable Investing
Margaux Hall on Drug Pricing Negotiation
Bill Hoagland on Debt-Ceiling Negotiations
Daniel Horwitz on Trump Indictment Strengths
Gottlieb on the Future of Crypto Policy, Law
The PFAS Problem, Regulatory and Other Issues
Crisis of Confidence, Regional Banks’ Future
The FTC’s Evolving Approach to Assessing M&A
The Biggest Tech-Regulation Questions
Energy's DC Opportunity, Risk with Schneider
Mulvaney on Crypto, the CFPB, and More